Kevin Feeley

Insider Reports History

Reporting-owner location: Stamford, CT
Latest reporting-owner signature: /s/ Bridget Brown, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kevin Feeley

Form 4 holding CHIEF FINANCIAL OFFICER

GeneDx Holdings Corp.

Security class: Restricted Stock Unit
Shares / value: 21,590
Estimated value: $4,611,019
Report date: 16 Jun 2026
Price: $94.58
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount

Form 4 holding CHIEF FINANCIAL OFFICER

GeneDx Holdings Corp.

Security class: Class A Common Stock
Shares / value: 39,954
Estimated value: $2,457,310
Report date: 16 Jun 2026
Price: $61.50
Ownership: Direct

Form 4 holding CHIEF FINANCIAL OFFICER

GeneDx Holdings Corp.

Security class: Employee Stock Option (Right to Buy)
Shares / value: 4,982
Estimated value
Report date: 30 Sep 2025
Price
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Kevin Feeley

4 WGS

GeneDx Holdings Corp.

Report period: 16 Jun 2026
Transactions: 5
Transaction value: -$226,597
Accepted by SEC: 18 Jun 2026, 16:11
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Jun 2026
Transactions: 3
Transaction value: -$68,073
Accepted by SEC: 11 Jun 2026, 16:12
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Jun 2026
Transactions: 3
Transaction value: -$19,092
Accepted by SEC: 03 Jun 2026, 16:16
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Apr 2026
Transactions: 3
Transaction value: -$25,555
Accepted by SEC: 01 May 2026, 16:24
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 26 Mar 2026
Transactions: 7
Transaction value: -$557,051
Accepted by SEC: 30 Mar 2026, 17:38
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 15 Mar 2026
Transactions: 7
Transaction value: -$438,203
Accepted by SEC: 17 Mar 2026, 18:39
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Mar 2026
Transactions: 3
Transaction value: -$111,045
Accepted by SEC: 11 Mar 2026, 16:28
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 06 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Mar 2026, 07:56
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 03 Mar 2026
Transactions: 5
Transaction value: -$486,370
Accepted by SEC: 05 Mar 2026, 17:49
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Mar 2026
Transactions: 3
Transaction value: -$22,248
Accepted by SEC: 03 Mar 2026, 16:38
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Jan 2026
Transactions: 4
Transaction value: -$29,794
Accepted by SEC: 02 Feb 2026, 16:33
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Dec 2025
Transactions: 13
Transaction value: -$554,616
Accepted by SEC: 18 Dec 2025, 17:20
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Dec 2025
Transactions: 3
Transaction value: -$201,648
Accepted by SEC: 11 Dec 2025, 16:31
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Dec 2025
Transactions: 3
Transaction value: -$61,276
Accepted by SEC: 03 Dec 2025, 16:18
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Oct 2025
Transactions: 3
Transaction value: -$52,978
Accepted by SEC: 31 Oct 2025, 16:41
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 30 Sep 2025
Transactions: 9
Transaction value: -$675,554
Accepted by SEC: 01 Oct 2025, 16:18
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4/A WGS

GeneDx Holdings Corp.

Report period: 16 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Sep 2025, 21:50
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Sep 2025
Transactions: 4
Transaction value: -$162,886
Accepted by SEC: 11 Sep 2025, 16:06
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Sep 2025
Transactions: 3
Transaction value: -$47,556
Accepted by SEC: 03 Sep 2025, 18:31
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Jul 2025
Transactions: 3
Transaction value: -$40,860
Accepted by SEC: 31 Jul 2025, 16:06
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Jul 2025
Transactions: 3
Transaction value: -$450,180
Accepted by SEC: 11 Jul 2025, 16:04
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Jul 2025
Transactions: 2
Transaction value: -$122,471
Accepted by SEC: 03 Jul 2025, 14:31
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Jun 2025
Transactions: 3
Transaction value: -$241,539
Accepted by SEC: 18 Jun 2025, 16:14
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Jun 2025
Transactions: 3
Transaction value: -$91,848
Accepted by SEC: 11 Jun 2025, 16:05
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Jun 2025
Transactions: 3
Transaction value: -$26,366
Accepted by SEC: 03 Jun 2025, 17:30
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Apr 2025
Transactions: 4
Transaction value: -$20,013
Accepted by SEC: 01 May 2025, 19:46
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4/A WGS

GeneDx Holdings Corp.

Report period: 09 Apr 2025
Transactions: 11
Transaction value: -$1,272,965
Accepted by SEC: 09 May 2025, 17:56
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 26 Mar 2025
Transactions: 4
Transaction value: -$836,211
Accepted by SEC: 28 Mar 2025, 16:07
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Mar 2025
Transactions: 3
Transaction value: -$87,334
Accepted by SEC: 11 Mar 2025, 17:42
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Mar 2025
Transactions: 3
Transaction value: -$27,128
Accepted by SEC: 04 Mar 2025, 16:36
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Jan 2025
Transactions: 3
Transaction value: -$21,582
Accepted by SEC: 31 Jan 2025, 17:47
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 07 Jan 2025
Transactions: 6
Transaction value: -$2,964,859
Accepted by SEC: 10 Jan 2025, 17:54
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 02 Jan 2025
Transactions: 3
Transaction value: -$108,737
Accepted by SEC: 06 Jan 2025, 18:04
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Dec 2024
Transactions: 3
Transaction value: -$286,139
Accepted by SEC: 18 Dec 2024, 18:21
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Dec 2024
Transactions: 3
Transaction value: -$86,836
Accepted by SEC: 11 Dec 2024, 19:18
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Dec 2024
Transactions: 3
Transaction value: -$20,617
Accepted by SEC: 03 Dec 2024, 19:21
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 21 Nov 2024
Transactions: 9
Transaction value: -$1,645,810
Accepted by SEC: 25 Nov 2024, 18:21
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Oct 2024
Transactions: 3
Transaction value: -$18,248
Accepted by SEC: 31 Oct 2024, 17:14
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Sep 2024
Transactions: 3
Transaction value: -$99,050
Accepted by SEC: 18 Sep 2024, 16:26
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Sep 2024
Transactions: 3
Transaction value: -$29,830
Accepted by SEC: 11 Sep 2024, 20:14
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Sep 2024
Transactions: 3
Transaction value: -$8,308
Accepted by SEC: 04 Sep 2024, 20:10
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Jul 2024
Transactions: 3
Transaction value: -$9,190
Accepted by SEC: 31 Jul 2024, 16:39
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Jun 2024
Transactions: 3
Transaction value: -$74,908
Accepted by SEC: 18 Jun 2024, 17:18
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Jun 2024
Transactions: 3
Transaction value: -$22,303
Accepted by SEC: 11 Jun 2024, 16:14
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Jun 2024
Transactions: 3
Transaction value: -$5,384
Accepted by SEC: 04 Jun 2024, 16:20
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Apr 2024
Transactions: 3
Transaction value: -$12,185
Accepted by SEC: 30 Apr 2024, 16:27
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 26 Mar 2024
Transactions: 6
Transaction value: -$398,767
Accepted by SEC: 17 Mar 2025, 21:50
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Mar 2024
Transactions: 3
Transaction value: -$34,455
Accepted by SEC: 19 Mar 2024, 16:14
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 12 Mar 2024
Transactions: 1
Transaction value: -$8,574
Accepted by SEC: 13 Mar 2024, 16:28
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Mar 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 12 Mar 2024, 17:27
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Mar 2024
Transactions: 3
Transaction value: -$2,580
Accepted by SEC: 05 Mar 2024, 16:33
Role: CHIEF FINANCIAL OFFICER
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Dec 2023
Transactions: 3
Transaction value: -$6,366
Accepted by SEC: 19 Dec 2023, 21:24
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Dec 2023
Transactions: 3
Transaction value: -$1,462
Accepted by SEC: 12 Dec 2023, 16:04
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Dec 2023
Transactions: 3
Transaction value: -$478
Accepted by SEC: 05 Dec 2023, 16:45
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Sep 2023
Transactions: 3
Transaction value: -$11,409
Accepted by SEC: 19 Sep 2023, 18:08
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Sep 2023
Transactions: 3
Transaction value: -$4,180
Accepted by SEC: 12 Sep 2023, 18:40
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Sep 2023
Transactions: 3
Transaction value: -$1,178
Accepted by SEC: 06 Sep 2023, 16:56
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 Jun 2023
Transactions: 4
Transaction value: -$17,473
Accepted by SEC: 21 Jun 2023, 16:06
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Jun 2023
Transactions: 3
Transaction value: -$5,860
Accepted by SEC: 13 Jun 2023, 17:19
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Jun 2023
Transactions: 3
Transaction value: -$1,841
Accepted by SEC: 05 Jun 2023, 16:42
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 16 May 2023
Transactions: 1
Transaction value: -$9,852
Accepted by SEC: 18 May 2023, 19:22
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 29 Apr 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 May 2023, 20:32
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 26 Apr 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 Apr 2023, 19:39
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 09 Mar 2023
Transactions: 3
Transaction value: -$11,469
Accepted by SEC: 13 Mar 2023, 19:25
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

GeneDx Holdings Corp.

Report period: 01 Mar 2023
Transactions: 3
Transaction value: -$4,662
Accepted by SEC: 03 Mar 2023, 16:43
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

Sema4 Holdings Corp.

Report period: 09 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Dec 2022, 15:12
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

Sema4 Holdings Corp.

Report period: 01 Dec 2022
Transactions: 3
Transaction value: -$3,361
Accepted by SEC: 05 Dec 2022, 17:16
Role: Chief Financial Officer
Next action: Open filing details

4 WGS

Sema4 Holdings Corp.

Report period: 01 Sep 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 08 Sep 2022, 20:46
Role: Chief Financial Officer
Next action: Open filing details

3 WGS

Sema4 Holdings Corp.

Report period: 25 Aug 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 02 Sep 2022, 16:06
Role: Chief Financial Officer
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Kevin Feeley

Insider Reports Filed by Kevin Feeley